Thought Leadership
What ACA's Uncertain Future Means for Biologics Patents
February 27, 2020
Ted Mathias, Stacie L. Ropka, PhD, and Rebecca Clegg
Law360

Axinn partners Ted Mathias, Stacie Ropka, and associate Rebecca Clegg authored the Law360 article, "What ACA's Uncertain Future Means for Biologics Patents." 

Click here to access the article. A subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.